The 2018 SUD waiver expanded residential treatment coverage, enabling certification of new providers
After almost two decades of the clinical use of GLP-1 for T2D and 10 years after the first GLP-1 medicine, liraglutide, was approved for #weight loss in people with obesity, the next decade may bring even greater progress, introducing more powerful GLP-1 medicines while expanding the utility of GLP-1 therapeutics beyond currently established #cardiometabolic disorders #GLP #obesity #publichealth #medicines #pharmacology Jean-Michel Dogns Post The benefits of GLP-1 drugs beyond obesity Excellent review on the Glucagon-like peptide1based medicines #diabetes and weight lossindependent actions
Sanches SC, Ramalho LN, Augusto MJ, da Silva DM, Ramalho FS (2015) Nonalcoholic steatohepatitis: a search for factual animal models
If you experience severe, persistent abdominal pain, fever, or jaundice while taking Ozempic, contact your GP promptly, call NHS 111 for advice outside normal hours, or seek emergency care
Type VI is known as the kyphoscoliosis type, and in this there is a deficiency of lysyl hydroxylase
doi: 10.1124/jpet.119.258152
